1.Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435.
2.Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10:19–24.
3.Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, et al. Understanding weight gain at menopause. Climacteric. 2012;15:419–29.
4.Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. (Lond) 2008;32:949–58.
5.Izumi S, Muano T, Mori A, Kika G, Okuwaki S. Common carotid artery stiffness, cardiovascular function and lipid metabolism after menopause. Life Sci. 2006;78:1696–701.
6. Rendell M, Hulthén UL, Törnquist C, Groop L, Mattiasson I. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab. 2001;86:744–49.
7.Newson L. Menopause and cardiovascular disease. Post Reprod Health. 2018;24:44–9.
8.Carrero JJ, Qureshi AR, Parini P, Arver S, Lindholm B, Bárány P, Heimbürger O. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol. 2009;20:613–20.
9.Bobjer J, Katrinaki M, Tsatsanis C, Giwercman YL, Giwercman A. Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. PLoS One. 2012;8:e61466.
10.Störk S, Bots ML, Grobbee DE, Van Der Schouw YT. Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. J Intern Med. 2008;264:245–53.
11.Maggio M, Ceda GP, Lauretani F, Bandinelli S, Corsi AM, Giallauria F, et al. SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab. 2001;96:1053–9.
12.Gaskins AJ, Wilchesky M, Mumford SL, Whitcomb BW, Browne RW, Wactawski-Wende J, et al. Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol. 2012;175:423–31.
13.Blum CA, Müller B, Huber P, Kraenzlin M, Schindler C, De Geyter C, et al. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab. 2005;90:3230–5.
14.Wunder DM, Yared M, Bersinger NA, Widmer D, Kretschmer R, Birkhauser MH, et al. Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. Eur J Endocrinol. 2006;155:137–42.
15.Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–33.
16.Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.
17.Chakrabarti S, Lekontseva O and Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life 2008;60:376–82.
18.Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol. 2010;120:105–15.
19.Gray GA, Sharif I, Webb DJ, Seckl JR et al. Oestrogen and the cardiovascular system: the good, the bad and the puzzling. Trends Pharmacol Sci. 2001;22:152–6.
20.MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, et al. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res. 1997;81:355–62.
21.Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, et al. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem. 2003;278:2118–23.
22.Kubes P, Kurose I and Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol. 1994;267:H931–37.
23.Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB, et al. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci. USA 1993;90:9813–7.
24.Niu XF, Smith CW and Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133–40.
25.Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R. et al. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest. 1999;104:503–13.
26.Korpelainen EI, Gamble JR, Smith WB, Goodall GJ, Qiyu S, Woodcock JM, et al. The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration. Proc Natl Acad Sci. USA 1993;90:11137–41.
27.Camussi G, Albano E, Tetta C, Bussolino F. The molecular action of tumor necrosis factor-alpha. Eur J Biochem. 1991;202:3–14.
28.Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM–1), vascular cell adhesion molecule 1 (VCAM–1), and E-selectin through nuclear factor-κB activation in endothelial cells. J Biol Chem. 2001;276:7614–20.
29.Stirone C, Duckles SP, Krause DN, Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol. 2005;68:959–65.
30.Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:c1603–1616.
31.Zhao Y, Nichols JE, Valdez R, Mendelson CR, Simpson ER. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein–1 binding site upstream of promoter 1.4. Mol Endocrinol. 1996;10:1350–7.
32.Wander K, Brindle E and O’Connor KA. C-reactive protein across the menstrual cycle. Am J Phys Anthropol. 2008;136:138–46.
33.Gohlke-Barwolf C. Coronary artery disease—is menopause a risk factor? Basic Res Cardiol. 2000;95:177–83.
34.Romero-Aleshire MJ, Diamond-Stanic MK, Hasty AH, endelson CR, Simpson ER. Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol. 2009;297:R587–92.